{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:31:28Z","timestamp":1773297088771,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T00:00:00Z","timestamp":1147305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T00:00:00Z","timestamp":1147305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1038\/sj.gt.3302766","type":"journal-article","created":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T09:51:34Z","timestamp":1147341094000},"page":"1300-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice"],"prefix":"10.1038","volume":"13","author":[{"given":"C","family":"Rivi\u00e8re","sequence":"first","affiliation":[]},{"given":"O","family":"Danos","sequence":"additional","affiliation":[]},{"given":"A M","family":"Douar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,5,11]]},"reference":[{"key":"BF3302766_CR1","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","volume":"93","author":"PD Kessler","year":"1996","unstructured":"Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082\u201314087.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302766_CR2","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/jvi.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098\u20138108.","journal-title":"J Virol"},{"key":"BF3302766_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/JVI.74.3.1436-1442.2000","volume":"74","author":"X Xiao","year":"2000","unstructured":"Xiao X, Li J, Tsao YP, Dressman D, Hoffman EP, Watchko JF . Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy. J Virol 2000; 74: 1436\u20131442.","journal-title":"J Virol"},{"key":"BF3302766_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jgm.665","volume":"7","author":"BK Kaspar","year":"2005","unstructured":"Kaspar BK, Roth DM, Lai NC, Drumm JD, Erickson DA, McKirnan MD et al. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus. J Gene Med 2005; 7: 316\u2013324.","journal-title":"J Gene Med"},{"key":"BF3302766_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood-2004-06-2501","volume":"105","author":"VM Rivera","year":"2005","unstructured":"Rivera VM, Gao GP, Grant RL, Schnell MA, Zoltick PW, Rozamus LW et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 2005; 105: 1424\u20131430.","journal-title":"Blood"},{"key":"BF3302766_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/7439","volume":"5","author":"JP Greelish","year":"1999","unstructured":"Greelish JP, Su LT, Lankford EB, Burkman JM, Chen H, Konig SK et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med 1999; 5: 439\u2013443.","journal-title":"Nat Med"},{"key":"BF3302766_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/73464","volume":"24","author":"MA Kay","year":"2000","unstructured":"Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257\u2013261.","journal-title":"Nat Genet"},{"key":"BF3302766_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/1043034041361190","volume":"15","author":"TR Flotte","year":"2004","unstructured":"Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004; 15: 93\u2013128.","journal-title":"Hum Gene Ther"},{"key":"BF3302766_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm0397-306","volume":"3","author":"KJ Fisher","year":"1997","unstructured":"Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997; 3: 306\u2013312.","journal-title":"Nat Med"},{"key":"BF3302766_CR10","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","volume":"101","author":"CS Manno","year":"2003","unstructured":"Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963\u20132972.","journal-title":"Blood"},{"key":"BF3302766_CR11","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","volume":"74","author":"N Chirmule","year":"2000","unstructured":"Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P et al. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000; 74: 2420\u20132425.","journal-title":"J Virol"},{"key":"BF3302766_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/hum.1998.9.4-477","volume":"9","author":"WC Manning","year":"1998","unstructured":"Manning WC, Zhou S, Bland MP, Escobedo JA, Dwarki V . Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477\u2013485.","journal-title":"Hum Gene Ther"},{"key":"BF3302766_CR13","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1128\/JVI.72.12.9795-9805.1998","volume":"72","author":"CL Halbert","year":"1998","unstructured":"Halbert CL, Standaert TA, Wilson CB, Miller AD . Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795\u20139805.","journal-title":"J Virol"},{"key":"BF3302766_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1128\/JVI.74.4.1761-1766.2000","volume":"74","author":"M Moskalenko","year":"2000","unstructured":"Moskalenko M, Chen L, van Roey M, Donahue BA, Snyder RO, McArthur JG et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761\u20131766.","journal-title":"J Virol"},{"key":"BF3302766_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/mthe.2001.0449","volume":"4","author":"H Chao","year":"2001","unstructured":"Chao H, Monahan PE, Liu Y, Samulski RJ, Walsh CE . Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. Mol Ther 2001; 4: 217\u2013222.","journal-title":"Mol Ther"},{"key":"BF3302766_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1006\/mthe.2002.0580","volume":"5","author":"TJ Fraites Jr","year":"2002","unstructured":"Fraites Jr TJ, Schleissing MR, Shanely RA, Walter GA, Cloutier DA, Zolotukhin I et al. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol Ther 2002; 5: 571\u2013578.","journal-title":"Mol Ther"},{"key":"BF3302766_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","volume":"103","author":"VR Arruda","year":"2004","unstructured":"Arruda VR, Schuettrumpf J, Herzog RW, Nichols TC, Robinson N, Lotfi Y et al. Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood 2004; 103: 85\u201392.","journal-title":"Blood"},{"key":"BF3302766_CR18","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1128\/JVI.77.4.2768-2774.2003","volume":"77","author":"B Hauck","year":"2003","unstructured":"Hauck B, Xiao W . Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol 2003; 77: 2768\u20132774.","journal-title":"J Virol"},{"key":"BF3302766_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","volume":"10","author":"MJ Blankinship","year":"2004","unstructured":"Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004; 10: 671\u2013678.","journal-title":"Mol Ther"},{"key":"BF3302766_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005; 23: 321\u2013328.","journal-title":"Nat Biotechnol"},{"key":"BF3302766_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","volume":"59","author":"K Erles","year":"1999","unstructured":"Erles K, Sebokova P, Schlehofer JR . Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999; 59: 406\u2013411.","journal-title":"J Med Virol"},{"key":"BF3302766_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J . Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574\u20131583.","journal-title":"Gene Therapy"},{"key":"BF3302766_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/sj.gt.3300995","volume":"6","author":"R Parks","year":"1999","unstructured":"Parks R, Evelegh C, Graham F . Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Therapy 1999; 6: 1565\u20131573.","journal-title":"Gene Therapy"},{"key":"BF3302766_CR24","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","volume":"73","author":"W Xiao","year":"1999","unstructured":"Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM . Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994\u20134003.","journal-title":"J Virol"},{"key":"BF3302766_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/viro.1996.0367","volume":"221","author":"S Muramatsu","year":"1996","unstructured":"Muramatsu S, Mizukami H, Young NS, Brown KE . Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 1996; 221: 208\u2013217.","journal-title":"Virology"},{"key":"BF3302766_CR26","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1128\/jvi.71.9.6823-6833.1997","volume":"71","author":"JA Chiorini","year":"1997","unstructured":"Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM . Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997; 71: 6823\u20136833.","journal-title":"J Virol"},{"key":"BF3302766_CR27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/JVI.73.2.1309-1319.1999","volume":"73","author":"JA Chiorini","year":"1999","unstructured":"Chiorini JA, Kim F, Yang L, Kotin RM . Cloning and characterization of adeno-associated virus type 5. J Virol 1999; 73: 1309\u20131319.","journal-title":"J Virol"},{"key":"BF3302766_CR28","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302766_CR29","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381\u20136388.","journal-title":"J Virol"},{"key":"BF3302766_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.virol.2004.10.012","volume":"330","author":"S Mori","year":"2004","unstructured":"Mori S, Wang L, Takeuchi T, Kanda T . Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology 2004; 330: 375\u2013383.","journal-title":"Virology"},{"key":"BF3302766_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1006\/mthe.2000.0219","volume":"2","author":"H Chao","year":"2000","unstructured":"Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE . Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619\u2013623.","journal-title":"Mol Ther"},{"key":"BF3302766_CR32","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/JVI.75.13.6199-6203.2001","volume":"75","author":"M Hildinger","year":"2001","unstructured":"Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM . Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199\u20136203.","journal-title":"J Virol"},{"key":"BF3302766_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0166-0934(97)00198-5","volume":"71","author":"E Tobiasch","year":"1998","unstructured":"Tobiasch E, Burguete T, Klein-Bauernschmitt P, Heilbronn R, Schlehofer JR . Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods 1998; 71: 17\u201325.","journal-title":"J Virol Methods"},{"key":"BF3302766_CR34","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1073\/pnas.0937739100","volume":"100","author":"G Gao","year":"2003","unstructured":"Gao G, Alvira MR, Somanathan S, Lu Y, Vandenberghe LH, Rux JJ et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci USA 2003; 100: 6081\u20136086.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302766_CR35","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","volume":"102","author":"D Grimm","year":"2003","unstructured":"Grimm D, Zhou S, Nakai H, Thomas CE, Storm TA, Fuess S et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003; 102: 2412\u20132419.","journal-title":"Blood"},{"key":"BF3302766_CR36","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","volume":"72","author":"K Jooss","year":"1998","unstructured":"Jooss K, Yang Y, Fisher KJ, Wilson JM . Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212\u20134223.","journal-title":"J Virol"},{"key":"BF3302766_CR37","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1128\/JVI.74.17.8003-8010.2000","volume":"74","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Chirmule N, Gao G, Wilson J . CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J Virol 2000; 74: 8003\u20138010.","journal-title":"J Virol"},{"key":"BF3302766_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jgm.175","volume":"3","author":"A Sarukhan","year":"2001","unstructured":"Sarukhan A, Soudais C, Danos O, Jooss K . Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med 2001; 3: 260\u2013270.","journal-title":"J Gene Med"},{"key":"BF3302766_CR39","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/sj.gt.3302539","volume":"12","author":"L Wang","year":"2005","unstructured":"Wang L, Cao O, Swalm B, Dobrzynski E, Mingozzi F, Herzog RW . Major role of local immune responses in antibody formation to factor IX in AAV gene transfer. Gene Therapy 2005; 12: 1453\u20131464.","journal-title":"Gene Therapy"},{"key":"BF3302766_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/mthe.2000.0045","volume":"1","author":"W Xiao","year":"2000","unstructured":"Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM . Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000; 1: 323\u2013329.","journal-title":"Mol Ther"},{"key":"BF3302766_CR41","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood.V97.12.3733","volume":"97","author":"Y Ge","year":"2001","unstructured":"Ge Y, Powell S, Van Roey M, McArthur JG . Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 2001; 97: 3733\u20133737.","journal-title":"Blood"},{"key":"BF3302766_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.gt.3302144","volume":"11","author":"YC Zhang","year":"2004","unstructured":"Zhang YC, Powers M, Wasserfall C, Brusko T, Song S, Flotte T et al. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Therapy 2004; 11: 233\u2013240.","journal-title":"Gene Therapy"},{"key":"BF3302766_CR43","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2003-11-3845","volume":"103","author":"P Chenuaud","year":"2004","unstructured":"Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Cherel Y, Casadevall N et al. Autoimmune anemia in macaques following erythropoietin gene therapy. Blood 2004; 103: 3303\u20133304.","journal-title":"Blood"},{"key":"BF3302766_CR44","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1182\/blood-2003-11-3852","volume":"103","author":"G Gao","year":"2004","unstructured":"Gao G, Lebherz C, Weiner DJ, Grant R, Calcedo R, McCullough B et al. Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 2004; 103: 3300\u20133302.","journal-title":"Blood"},{"key":"BF3302766_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.gt.3300572","volume":"5","author":"V Budker","year":"1998","unstructured":"Budker V, Zhang G, Danko I, Williams P, Wolff J . The efficient expression of intravascularly delivered DNA in rat muscle. Gene Therapy 1998; 5: 272\u2013276.","journal-title":"Gene Therapy"},{"key":"BF3302766_CR46","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/jgm.716","volume":"7","author":"P Gonin","year":"2005","unstructured":"Gonin P, Arandel L, Van Wittenberghe L, Marais T, Perez N, Danos O . Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb. J Gene Med 2005; 7: 782\u2013791.","journal-title":"J Gene Med"},{"key":"BF3302766_CR47","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1128\/JVI.75.4.1824-1833.2001","volume":"75","author":"AM Douar","year":"2001","unstructured":"Douar AM, Poulard K, Stockholm D, Danos O . Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol 2001; 75: 1824\u20131833.","journal-title":"J Virol"},{"key":"BF3302766_CR48","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224\u20132232.","journal-title":"J Virol"},{"key":"BF3302766_CR49","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/jvi.71.7.5236-5243.1997","volume":"71","author":"J Li","year":"1997","unstructured":"Li J, Samulski RJ, Xiao X . Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol 1997; 71: 5236\u20135243.","journal-title":"J Virol"},{"key":"BF3302766_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/mthe.1999.0010","volume":"1","author":"JM Allen","year":"2000","unstructured":"Allen JM, Halbert CL, Miller AD . Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol Ther 2000; 1: 88\u201395.","journal-title":"Mol Ther"},{"key":"BF3302766_CR51","volume-title":"Current Protocols in Human Genetics","author":"RO Snyder","year":"1996","unstructured":"Snyder RO, Xiao X, Samulski RJ . Production of recombinant adeno-associated viral vectors. In: Dracopoli N, Hains J, Krof B, Moir D, Morton C, Seidman C, Seidman J, Smith D (eds). Current Protocols in Human Genetics. John Wiley and Sons: New York, 1996, pp 12.11.11\u201312.11.24."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302766","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:41:57Z","timestamp":1648615317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,11]]},"references-count":51,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["BF3302766"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302766","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,11]]},"assertion":[{"value":"27 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}